Technologies

On-Device AI Healthcare Company Noul Announces 2 Clinical Performance Studies at Pan-African Malaria Conference

  • by

​ miLab showed almost equivalent to WHO-certified first-degree microscopy experts: Sensitivity of 94.4%, Specificity of 98.1% African authority on malaria diagnosis said “miLab is a potential game changer in accelerating access to parasitological confirmation” YONGIN,… Read More »On-Device AI Healthcare Company Noul Announces 2 Clinical Performance Studies at Pan-African Malaria Conference